ABOUT US

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH.

Executive Team

Our management team has broad expertise across scientific and business operations, inventing compounds, and advancing product candidates through clinical development.

Vipin K. Garg, Ph.D.
President And Chief Executive Officer
Greg Weaver, MBA
Chief Financial Officer
Scot Roberts, Ph.D.
Chief Scientific Officer
M. Scott Harris, M.D.
Chief Medical Officer
Bertrand Georges, Ph.D.
Chief Technology Officer
Raymond Jordt, MBA
Chief Business Officer

Senior Leadership Team

Tony Blandin
Vice President, Quality and Compliance Management
Randy Brown
Vice President, Clinical Operations
Sarah K. Browne
Vice President, Clinical Development
Vyjayanthi Krishnan
Vice President, Product Development
Siavoche Siassi
Vice President, Commercial Strategy And Portfolio Development
Karen Smith
Vice President, Finance
Andrew Shutterly, M.S.
Corporate Controller and Acting CFO
Jay Yang
Vice President, Biostatistics and Data Management

Board of Directors

Scientific Advisory Boards

Obesity

Co-Director Of The Center For Weight Management And Wellness (CWMW), Division Of Endocrinology, Diabetes, And Hypertension, Brigham And Women’s Hospital
Sanford I. Weill Professor Of Metabolic Research And Director Of The Comprehensive Weight Control Center, Division Of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine
Medical Director And Principal Investigator Of Velocity Clinical Research (Formerly National Research Institute)
William H. Danforth Professor Of Medicine, Director Of The Center For Human Nutrition, Director Of The Center For Applied Research Sciences, Chief Of The Division Of Geriatrics And Nutritional Sciences, And Director Of The Weight Management Program, Washington University School Of Medicine, St. Louis, Missouri
Professor Of Medicine And Medicine Education At Northwestern University Feinberg School Of Medicine, And Director Of The Center For Lifestyle Medicine
Professor Emerita, Pennington Biomedical, Baton Rouge, Louisiana

MASH

David W Crabb Professor & Vice President For Academic Affairs, Indiana University School Of Medicine & Indiana University Health
Professor Of Medicine, Director Of Hepatology, At University Of California At San Diego
Director, Cedars-Sinai Medical Center Fatty Liver Program

Partnerships

We believe strategic partnerships break barriers to innovation and we continuously evaluate partnership opportunities. Contact Raymond Jordt, Chief Business Officer, for partnership inquiries.

For partnership opportunities contact:

Raymond Jordt
Chief Business Officer
rjordt@altimmune.com